PHOSP-COVID Study
The PHOSP-COVID study is a national consortium of leading researchers and clinicians from across the UK being led by the NIHR Leicester Biomedical Research Centre. The key focus of the study looks at analysing and building solutions for patients following discharge from hospital with clinician suspected COVID-19, and whether there are long-term effects on their health. The research will address gaps around the ongoing effects of the disease.
The study seeks to understand what the optimal continued medical, psychological and rehabilitation needs for this group of patients will be to enable them to make as full a recovery as possible. The PHOSP-COVID team will then develop trials of new strategies for clinical care, including personalised treatments for groups of patients based on the particular disease characteristics they show as a result of having COVID-19 to improve their long-term health.